J. Sulcova et al., AMNIOTIC-FLUID 17-HYDROXYPROGESTERONE IN EARLY-PREGNANCY, Journal of steroid biochemistry and molecular biology, 51(5-6), 1994, pp. 315-318
The results of measurement of 17-hydroxyprogesterone (17-OH-P) in 125
samples of amniotic fluid (AF) from early amniocenteses are presented.
The fetuses from all pregnancies studied were unaffected by congenita
l adrenal hyperphasia caused by 21-hydroxylase deficiency. The AF 17-O
H-P level increases slightly but significantly between the 11th and 15
th week of gestation, with a maximum in the 14th week. There is no dif
ference between the values measured in male and female fetuses. The AF
17-OH-P levels from the early gestation were compared with those from
the 16th-22nd week of pregnancy (published previously). The overall d
ifferences of AF 17-OH-P concentrations when considered in all gestati
onal age groups in the whole period 12-22 weeks were statistically ins
ignificant. Thus, the biochemical prenatal diagnosis of congenital adr
enal hyperplasia due to 21-hydroxylase deficiency and control of its e
arly fetal treatment could be carried out starting from the end of the
first trimester in the same way as at the later period of gestation.